$11.11
+0.61 (+5.81%)
Open$11.20
Previous Close$10.50
Day High$11.51
Day Low$10.96
52W High$16.19
52W Low$5.46
Volume—
Avg Volume1.21M
Market Cap690.33M
P/E Ratio—
EPS$-5.59
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+66.3% upside
Current
$11.11
$11.11
Target
$18.48
$18.48
$13.35
$18.48 avg
$24.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 205.35M | 178.90M | 81.92M |
| Net Income | -233,587,709 | -183,158,161 | 13.19M |
| Profit Margin | -113.8% | -108.1% | 16.1% |
| EBITDA | -175,403,597 | -145,176,352 | 28.49M |
| Free Cash Flow | — | — | 20.59M |
| Rev Growth | +14.8% | +14.8% | +8.8% |
| Debt/Equity | 1.82 | 1.82 | 0.43 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |